About Project DNA

Improve your family’s future through insight into its past. Families affected with hereditary cancer syndromes are at high risk for developing multiple cancers at an early age. These cancers can have devastating effects on families.

The good news is that with appropriate screening, many of these cancers can be prevented. Unfortunately, physicians and patients have not been adequately educated about these syndromes and as a result, many families are not diagnosed.

Project DNA was designed to create simple but effective tools to help facilitate diagnosis, and provide educational materials that allow physicians and patients to develop appropriate screening programs.

Based on national guidelines, the screening recommendations are broken down into two major categories:

Smart Tools: A program that gathers information and generates a detailed “smart family history” which indicates whether an individual is at risk for a hereditary cancer syndrome.

Educational Materials: Designed for both physicians and patients, a rich database of information is at your fingertips. Just select a particular mutation or syndrome for detailed information about that syndrome and screening guidelines.

It’s our hope that all patients will fill out the smart family history, and appropriate, high-risk patients will be screened for hereditary cancer syndromes. By screening patients and identifying these syndromes early, we stand a better chance of preventing cancers from developing.

Board of Directors


Daniel G. Luba, M.D. | Chairman of the board, President of Project DNA

Dan Luba graduated from Boston University Medical School and completed his fellowship in gastroenterology at Stanford. He has been in private practice since 1991 and is the managing partner of Gastroenterology Consultants in Monterey, California. In addition to caring for patients, he continues to do research in new endoscopic techniques, Lynch syndrome, and systems based delivery of care.


Howard L. Hyman

Howard L. Hyman is Board Director and Executive Vice President of Fremont Bank, headquartered in Fremont, CA. Responsibilities include corporate branding, including growth in client affinity and employee engagement. He recently served as Alumnus of the year for Cal State East Bay and holds advanced certifications from the Stonier School of Banking and the Graduate Program in Bank Operations and Technology at Vanderbilt University. He serves on the Stanford Medical Cancer Council, the Cal-State East Bay Foundation, and the Fremont Bank Foundation. Previously he has helped develop Valley Montessori School in Livermore, the Fremont Symphony Orchestra, and the Fremont Education Foundation. He has been recognized as a leader and philanthropist with a passion for medicine; collecting antique medical reference books as a hobby. He is a member at Monterey Peninsula Country Club in Pebble Beach and the Krewe of Bacchus in New Orleans


Dr. Patrick Welton, Chief Executive Officer & Chief Investment Officer

Dr. Welton is the CEO and Chief Investment Officer of Welton Investment Corporation where he chairs the Investment Committee and actively participates in ongoing research. The firm and its affiliates manage specialized investment programs driven by scientific, quantitatively-driven processes for investors worldwide. As an investment leader, Dr. Welton has served on committees for the Managed Funds Association (MFA) and as a member of the Board of Directors of the National Futures Association (NFA) from 1997-2000. He is a frequent speaker on panels and at conferences globally and has authored numerous articles about alternative investments. Dr. Welton is currently a Trustee and investment committee Chair of a California foundation and a California pension plan. He is a cofounder of the private Welton Foundation which principally focuses on educational excellence, opportunity and access. He formerly cofounded Axios Data Analysis Systems, an early commercial entrant into large scale data mining and data fusion as applied to healthcare informatics.

Dr. Welton is a summa cum laude graduate of the University of Wisconsin with degrees in Molecular Biology and English. He completed graduate work in Biophysics as a Medical Scientist Training Program Scholar, and earned an MD from the University of California, Los Angeles (UCLA). He completed his postdoctoral training at Stanford University where he also served as Chief Resident in Therapeutic Radiology, and subsequently served on the clinical faculty for over 15 years. During his studies, he worked at the McArdle Laboratory for Cancer Research on an NIH grant and was principally involved in genetic sequencing and gene promoter region identification. He subsequently worked in UCLA Radiological Sciences and Biophysics on Positron Emission Tomography with a focus on neuroscience applications and neurological disease. He later participated in numerous clinical investigative trials in cancer therapeutics across multiple organ systems, and published reviews on the application of interstitial hyperthermia in head and neck oncology. He is Board Certified by the American Board of Radiology in Therapeutic Radiology.